Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.

ABSTRACT:

SUBMITTER: Lanamtieng T 

PROVIDER: S-EPMC12881082 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature